Zeng’s dedication to the best possible quality of care for proton therapy patients was echoed by all staff when asked about her work. She accepted the role of Medical Director in 2020 during a mission-critical period for the facility and shepherded the staff through the merger with Fred Hutch. Her commitment to excellence and leadership ensured that the facility could continue to deliver the highest quality of care during these significant transitions.
Ramesh Rengan, MD, PhD, FASTRO, who was the medical director at the facility prior to Zeng, said:
“Dr. Zeng has been an invaluable asset to Fred Hutch during her tenure as medical director. Her dedication to providing the highest quality cancer care has been evident through her leadership and expertise. On behalf of the entire team at Fred Hutch, we extend our deepest gratitude to Dr. Zeng for her years of service and contributions to advancing proton therapy.”
“It has been an incredible journey for the past 12 years,” said Zeng. “Since 2012, I have witnessed our growth and evolution of the facility into a beacon of hope and healing for our patients. When I reflect on the path we've traveled together, I cannot help but marvel at the transformations — from the pioneering early days through today, we have continually pushed boundaries and set new standards in proton therapy.”
Some of these technological advancements include upgrading all our patient treatment rooms to pencil beam scanning, the most advanced and precise way to deliver proton radiation, as well as updating the medical records system, recruiting world experts in proton therapy, and beginning leading-edge research on ultra-high-dose-rate radiation (FLASH).
“Dr. Zeng’s leadership has propelled the proton therapy facility towards groundbreaking advancements, while fostering a strong supportive environment for all team members,” said Randall K. McClure Jr., MBAHM, RTT, director of the proton therapy facility.
“I am so thankful to both the staff and the patients,” said Zeng. “The staff’s unwavering dedication and expertise have been the bedrock upon which our success stands. Our patients’ trust and courage inspire us daily, and it is their stories of resilience that remind us why our work is so profoundly important.”
Staff at the proton therapy facility shared glowing reflections on Dr. Zeng, noting her strong work ethic, calm demeanor and her willingness to always take the time to listen to people’s problems or concerns.
“Dr. Zeng’s leadership has been phenomenal,” said Bao-Ngoc Thi Nguyen, CMD, dosimetry manager, who often works closely with Zeng.
Nurse Manager, Amanda Naiker, RN, BSN, agreed:
“Dr. Zeng is an outstanding provider to work with. She is efficient, responsive, approachable, and always willing to teach. I have learned a great deal from her both in her role as physician and as leader. Her unwavering commitment to patient care and staff development has significantly enhanced the facility and our patients' experiences. Her leadership has truly set a benchmark for excellence.”
After much contemplation, Zeng decided to take on a new challenge where she can continue to serve Fred Hutch using the experiences and insights she has gained as medical director.
As the vice chair of Clinical Affairs, Zeng will work with a team to ensure Fred Hutch provides world-class patient care across all clinic locations, including the proton therapy facility. She will collaborate closely with the medical directors at all facilities, medical physicists and clinical and operational staff. As Fred Hutch continues to grow, her aim is to provide our patients with the same leading-edge level of care no matter at which location they are seen for treatment.
“I want to extend a heartfelt congratulations to Dr. Zeng in her new role," said McClure. "Building on her exemplary performance here I am excited to see her lead the proton therapy facility and the entire radiation oncology department into many new and exciting opportunities."
Zeng will be greatly missed in her proton therapy leadership role, although she will continue to see patients at the facility.
On September 1, Annemarie Shepherd, MD, will step into the role of medical director at the proton therapy facility. Shepherd joins Fred Hutch from Memorial Sloan Kettering Cancer Center in New York and The New York Proton Center, where she treated patients with thoracic cancers. We’ll introduce her in the September newsletter.